RPG Life Sciences: Pain management, oncology, rheumatology, cardio-vascular treatments

 RPG Life Sciences: Pain  management, oncology,  rheumatology, cardio-vascular  treatments


  • Strong brands in the Indian pharmaceutical industry 
    • –The company’s domestic formulations business benefits from its strong brands,  which  continue  to  enjoy healthy market  share  in  their  respective  therapeutic  segments.  Successful execution of these plans and their impact on the company’s revenue growth and profitability are key rating monitorable factors pain  management, oncology,  rheumatology, cardio-vascular  treatments etc.  
    • The  domestic  formulations  business  continues  to  be  its  major revenue driver with ~67% of total revenue in FY2024. 
  • Robust  capital  structure  and  strong  debt  servicing  indicators;  financial  flexibility  as  part  of  the  RPG  Group 
    • –Adequate retained cash flows and unencumbered cash and liquid investments limit RPGLS’ dependence on external debt.
    • With its debt-free status and improved operating performance, it has a robust capital structure and coverage metrics. 
    • Further, the company also  enjoys  financial  flexibility  as  part  of  the  RPG  Group. 
    • ICRA,  however,  will  continue  to  monitor  the  usage  of  free  cash, including  any  inorganic expansion and will assess the impact on RPGLS’ credit profile, in  case  of  any  material  change  in  its liquidity profile. 
  • Expansion  of  product  portfolio  and  geographical  presence  augur  well  for  growth  prospects
    • RPGLS  launched 12new products  in  FY2024and  17new  products  in 9MFY2025 in  its  domestic  formulations  business.  
    • Sales  from  new  products in domestic formulation have been inching up in terms of sales share and stood at around 25%of total sales for all launches since FY2019. 
    • ICRA notes the company’s focus on increasing its presence in existing geographies through new product launches in niche categories, and on exploring new markets. 
    • Successful execution of these plans and their impact on the company’s revenue growth and profitability are key rating monitorable factors.



RPG Life Sciences: To continue moving towards Life time high

  • For the full fiscal year FY24 too, the company achieved a 29% year-on-year increase in PAT 
  • Saw an expansion of EBITDA margin from 21.0% to 23.3% year-on-year. 
  • Revenue from operations, totaling Rs 582.05 crores, experienced a 14% Y-O-Y growth for FY24.
  • Top priority, Domestic Formulations, the biggest contributor to the Company’s business, recorded robust growth in both value and volume
  • To enter other specialties like Gastro and Derma to emerge as future growth drivers of Domestic Formulations business
  • Structural approach of cost optimization has helped explore newer avenues in operations to achieve cost efficiencies, helping to maintain 5-year uninterrupted Y-o-Y margin expansion trajectory for the past 5 consecutive years

 Thank you for contacting Rounaq! Please let us know how we can help you. 

Whatsapp: 7838491131

SEBI registered RA : Rounaq Bakshi
Waheguru

Comments

Post a Comment

Popular posts from this blog

Transcript of NMDC Limited post Q4 & FY 2024-25 Results

Image
Transcript of NMDC Limited post Q4 & FY 2024-25 Results Growth in PAT on an annual or a year-on-year 12-month basis of around 19% and PBT after exceptional item of around 16% Gold operations in Legacy, the first year was have also stabilized Legacy in the last 2 months, 3 months.  And hopefully, in this financial year, Legacy would also be showing good profits IMPORTS India which imports around 55 million, 60 million tons is likely to go up to 150 million to 160 million tons of import for India in terms of coking coal.  Have entered into arrangement with SAIL 60% of total sales as of date is routed through SAIL because send it to their stocking yard.  So based on the user charge, they also market mmdc products 40% still Nmdc market directly in terms of HR coils 2025 year will be much more substantially action packed in terms of NMDC Open new mines within India, coal and iron ore Outside India, we hope to acquire a few mines.  This will be a year where it will be ...
Read more

Looking to park some excess funds for the short term.?

Image
Looking to park some excess funds for the short term.  LiquidBeES by Nippon - has been the default choice for years. But lately, it’s become muscle memory to run everything past ChatGPT.  Just a quick: “Is there a better option than LiquidBeES?” It turns out, there is.  LIQUIDCASE by Zerodha AMC.  Difference was not subtle and decision was easier : - Expense ratio: Less than half of LiquidBeES - Net returns: ~6.2% vs ~5.7% (1-year annualized) - Same safety, same liquidity - AUM already >1/3rd of LiquidBeES in record time This is how discovery is changing. And this is how smart products go viral. Zerodha didn’t try to educate the market.  Discovery is no longer driven by ads or advisors.  It’s driven by habit, trust, and tools like ChatGPT. And when you get it right, traction follows fast. I won’t be surprised if LIQUIDCASE overtakes LiquidBeES in under 18 months. Thank you for contacting Rounaq! Please let us know how we can help you.  About me :...
Read more

𝐖𝐑𝐲 𝐃𝐨 ππ‘πˆπ¬ 𝐈𝐧𝐯𝐞𝐬𝐭 𝐒𝐧 𝐈𝐧𝐝𝐒𝐚?

Image
  𝐖𝐑𝐲 𝐃𝐨 ππ‘πˆπ¬ 𝐈𝐧𝐯𝐞𝐬𝐭 𝐒𝐧 𝐈𝐧𝐝𝐒𝐚? Whether you're living in the US, UAE, UK, or Singapore; India continues to be a hotspot for wealth creation. But why do so many NRIs still invest here? Here’s why πŸ‘‡ ✅ Higher Returns – Indian equity markets, mutual funds, and even fixed deposits offer attractive long-term returns. ✅ Tax-Free Income – Interest from NRE and FCNR deposits is tax-free in India. Plus, DTAA helps avoid double taxation. ✅ Currency Edge – You invest in INR, and with the right timing, your gains in foreign currency terms could be even higher. ✅ Diversification – Indian assets like gold, real estate, and stocks add balance to a global portfolio. ✅ Future Ready – Planning to return to India someday? Build your base early with property or retirement-focused investments. ✅ Emotional Roots – Beyond numbers, India is still home. πŸ’‘ Whether it’s for wealth creation, retirement planning, or building assets back home, India offers a solid mix of growth + stability...
Read more